1Tillett WS, Fraccis T. Scrological reaction in pneumonia with a nonprotein somatic fraction of the pneumococcus[J]. J Exp Med, 1930(52):561-571.
2Ross R. Atherosclerosis-an inflammatory disease [J]. N Eng J Med, 1999,340(2): 115-126.
3Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice:a statement for health care professionals from the centers for disease control and prevention and American heart association [J]. Circulation,2003,107(3):499-511.
4Ridker PM, Rifai N, Rose L, et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Eng J Med, 2002, 347(20): 1557-1565.
5Danesh J, Wheeler JG, Hirschfield GH, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease[J]. N Eng J Med, 2004,350(14):1387-1397.
6Torzewski J,Torzewski M, Bowyer DE,et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries [J]. Arterioscler Thromb Vasc Biol, 1998, 18(9):1386-1392.
7Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology [J]. Circulation,2003,107(3) :370-371.
8Calabro P, Willerson JT. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells [J]. Circulation,2003,108(16): 1930-1932.
9Jabs WJ, Logering BA, Gerke P, et al.The kidney as a second site of human Creactive protein formation in vivo [J].Eur J Immunol, 2003,33( 1 ): 152-161.
10Gould JM, Weiser JN. Expression of Creactive protein in the human respiratory tract[J]. Infect Immun, 2001, 69(3):1747-1754.
